4 ms·
Fortunately that supply can increase. Theoretically drug companies can close off the entire market or increase supply. They’re prohibited from raising prices i
by prepend 7y ago
Fortunately that supply can increase.
Theoretically drug companies can close off the entire market or increase supply. They’re prohibited from raising prices in the market. Since marginal cost is so low, I expect that they’ll keep selling st increased volumes.
It’s a bit odd that the US is taking this tack instead of just regulating drug prices domestically. But there’s a lot of odd things in the health system.
- droithomme 7y ago> instead of just regulating drug prices domestically Perhaps the hope is that US prices will fall, shortages in Canada might cause prices to go up a bit there, but in the end the open market will equalize with lower prices overall.
- dmix 7y agoIt will generate a significant amount of income for the Canadian economy and create cheaper drug prices for tons of people. It might be bumpy at the start as the supply side gets in line with the market, but it's better for both sides in the long run IMO.
- yellowarchangel 7y ago> instead of just regulating drug prices domestically The current administration is very anti-regulation, so this would be a bad move. Also, allowing Canadian drugs to enter the country will force current producers to lower pricers, which will organically (capitalism) reduce the price through competition.
- ijpoijpoihpiuoh 7y agoYou're missing the fact that one big reason the prices are so low in Canada is regulation. https://www.healthaffairs.org/doi/full/10.1377/hlthaff.20.3.92 https://www.healthaffairs.org/doi/full/10.1377/hlthaff.20.3.... What the administration is proposing is effectively to regulate drug prices, but outsource that work to Canada, since it's politically unpalatable to their base here in the US.
- skybrian 7y agoSounds good to me. Second-best, but that's true of a lot of things. They should do the same for Europe.
- ijpoijpoihpiuoh 7y agoI don't fundamentally mind the policy decision. It's bad for Canadians and good for Americans, although we give up some agency in the determination of our own prices by making this play. I just wish the messaging around this didn't have to be so disingenuous. Also, if I were Canada, I would ban the export of drugs to the United States if the US domestic price for the drug is higher than the Canadian price for the same drug. Because otherwise the effect would be that a single market would exist for the drug, and the average price in Canada would face upward pressure as a result. Although if they did this, an American administration bent on getting the same effect could cap all domestic drug prices to the prices paid by Canadians and skip the pointless importing step. I wonder how Canada would react to that? I guess if I were Canada at that point I would make drug price negotiations secret.
- skybrian 7y agoI don't think we know how prices would change in the long run? It could turn out is that increased volume of sales gives Canada more leverage with its suppliers as a larger buyer.
- munk-a 7y agoI think it's much more likely that Pharma manufacturers would cut supply to Canada and pressure the government to price match what US end users would end up paying - it's hard to tell but... I don't have a very optimistic view of the morals of drug manufacturers and this would be a highly convenient crow bar.
- ddingus 7y agoI will take it as a first step.
- arcticbull 7y agoIt could, but it could also be cut off by drug companies refusing to allow re-export when they negotiate prices with the provinces. I'm sure the provinces would take a 1-5% discount for avoiding re-export. Also, this isn't BC, Ontario or Quebec's problem -- the federal government doesn't administer this stuff, the provinces do. Y'all need to sort this out for yourselves.
- DenisM 7y ago> It’s a bit odd that the US is taking this tack instead of just regulating drug prices domestically. The net result of this drug policy is lower drug prices for US public, under the banner of "stop subsidizing the free-riders". The net result of the tariffs is higher wages for industrial workers, under the banner of "fighting the unfair China". Both are left-wing outcomes, dressed up as not just acceptable but enticing for the conservative public. Were there more efficient ways? Yes, we could reign in the pharma and force the 1% to raise wages for the 99%, but that would not be accepted by the conservative Americans, while this approach seems to be accepted.
- AaronFriel 7y agoThe net result of the former is lower drug prices for the US public and a more complex supply chain that will be (ab)used by our already overly complex healthcare supply chains in the US. More indecipherable drug prices and negative externalities from exporting and then re-importing drugs like higher carbon footprints don't seem desirable, even if they're more palatable to the direct policy-averse conservative public. The net result of tariffs is some combination of: higher costs on the goods purchased by Americans, lower wages paid to the workers making those good, and reduced demand on foreign goods (which may not have a substitute, which may depress the economy). The latter, reduced demand on foreign goods, may in turn hurt foreign economies, reducing their demand on our exports. Somewhere in that is "higher wages for industrial workers", but it's unlikely tariffs lead to that outcome except in a handful of cases where the US has production capacity available for a substitute good. US steel might be one of said exceptions, because we have large amounts of unused capacity and a comparable or better product, but aren't able to manufacture it as cheaply. It's highly unlikely tariffs on ... checks notes from [1] Alaska pollack (interesting!), child safety seats, and hydrometers are comparable. I don't expect we have huge amounts of latent labor supply just waiting to make these things or manufacturing facilities configured to do so, but I could be wrong. The net effect of a massive tax cut that disproportionately impacts the wealthy and tariffs that disproportionately affect (nay, target) consumption goods is a regressive tax hike on the majority of Americans. These aren't left-wing outcomes, they're just bad policies. [1] - https://ustr.gov/sites/default/files/enforcement/301Investigations/Tariff%20List%20%2883%20FR%2047974%2C%20as%20amended%20and%20modified%20by%2083%20FR%2049153%29.pdf https://ustr.gov/sites/default/files/enforcement/301Investig...
- m0zg 7y agoIt will also be regulating prices domestically, sort of. Trump mentioned introducing the "Favored Nations" clause. He just doesn't want to rely on that entirely. Regulating prices domestically == letting some idiot who had never run a business decide what products should cost. It's a dead end. Favored nations basically says you can't sell the product to us at a price that's higher you're charging your other customers, which, to me, makes more sense. You retain pricing flexibility, but not too much of it. I don't see why a European should pay less for a drug than a US person, who likely partially funded the early stages of development of that drug with her federal taxes. Another issue is that even _generic_ drugs are often wildly overpriced in the US. Canada (or some other country, such as e.g. India, which has a strong pharma industry) could pretty easily just make more of them and exert downward price pressure. What's unfolding before us here is historic. Previous administrations were all too beholden to Big Pharma to even contemplate any of this.